Medacta to Spotlight its Sports Medicine Lineup at ISAKOS 2025

Medacta Group SA is showcasing its expanded sports medicine portfolio next week at the 15th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) Congress in Munich, Germany (June 8-11).

Medacta bolstered its sports medicine offerings upon acquiring Parcus Medical in March from Anika Therapeutics. Among the expanded solutions being highlighted at the show (booth 03A) is the X-Twist anchor platform and Draw Tight all-suture anchor fixation systems. 

“I’ve been using X-Twist for three years. It has consistently delivered the quality and reliability I expect in my practice. The instrumentation is easy to use and intuitive, and the fixation is robust,” said Christopher E. Baker, M.D., from the Florida Orthopaedic Institute in Tampa. “This anchor can be used both knotless and as a knotted traditional anchor, offering a wide spectrum of options for suture preference, including tape. The X-Twist can easily be used for nearly any soft tissue repair within the shoulder and throughout the body.” 

The expanded portfolio boosts Medacta’s profile as a full-service partner for personalized soft tissue injury management and enhances its go-to-market strategy, supporting additional growth within the sports medicine business line, according to the company. Medacta also plans to capitalize on opportunities in the fast-growing U.S. ambulatory surgery center (ASC) market.

“Our Sports Medicine portfolio is built on a foundation of deep anatomical insight, enabling us to design personalized repair and reconstructive solutions that closely replicate natural joint anatomy. This approach not only enhances joint function and biomechanics but also drives higher patient satisfaction with the aim to deliver clinically superior outcomes,” Medacta CEO Francesco Siccardi stated.

The proprietary and advanced MySolutions Personalized Ecosystem provides the technological foundation for further expanding the personalization capabilities of Medacta’s sports medicine portfolio. Within this platform, MyPAO exemplifies the ways digital planning and 3D printing enable precise, patient-specific surgical execution during periacetabular osteotomy procedures.

All Medacta products are supported by the tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education with personalized, high-level educational pathways.

Medacta is a global player specializing in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta aims to improving patients’ care and well-being and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in more than 70 countries.